Concord Medical Services Holdings (FRA:C2C) EPS without NRI: €-2.49 (TTM As of Dec. 2025)


FRA:C2C Concord Medical Services Holdings Ltd FRA:C2C
56 GF Score
Price €6.25
GF Value €8.97
! 6 Warning Signs
View Full Analysis

What is Concord Medical Services Holdings EPS without NRI?

Concord Medical Services Holdings FRA:C2C 56 EPS without NRI is €-2.49 as of Dec. 2025. GuruFocus rates FRA:C2C with a GF Score™ of 56/100 and a GF Value™ of €8.97. The stock has 6 warning signs investors should review. Among 512 Healthcare Providers & Services companies, Concord Medical Services Holdings ranks better than 83.98% on this metric.

Concord Medical Services Holdings's earnings per share without non-recurring items for the six months ended in Dec. 2025 was €-0.99. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was €-2.49.

During the past 3 years, the average earnings per share (NRI) Growth Rate was 42.00% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 30.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Concord Medical Services Holdings's EPS without NRI or its related term are showing as below:

FRA:C2C' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -76   Med: 1.9   Max: 42
Current: 42

During the past 13 years, Concord Medical Services Holdings's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 42.00% per year. The lowest was -76.00% per year. And the median was 1.90% per year.

FRA:C2C's 3-Year EPS without NRI Growth Rate is ranked better than
83.98% of 512 companies
in the Healthcare Providers & Services industry
Industry Median: 11.55 vs FRA:C2C: 42.00

Concord Medical Services Holdings's EPS (Diluted) for the six months ended in Dec. 2025 was €-1.82. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-2.58.

Concord Medical Services Holdings's EPS (Basic) for the six months ended in Dec. 2025 was €-1.82. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was €-2.58.


Concord Medical Services Holdings  (FRA:C2C) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Concord Medical Services Holdings EPS without NRI Related Terms


Concord Medical Services Holdings EPS without NRI Historical Data

* Premium members only.

The historical data trend for Concord Medical Services Holdings's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Concord Medical Services Holdings EPS without NRI Chart

Concord Medical Services Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -25.47 -15.04 -10.21 -10.37 -2.65

Concord Medical Services Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.59 -2.62 -7.68 -1.50 -0.99

FRA:C2C vs CCEL, GBCS, CDIX: EPS without NRI Comparison

For the Medical Care Facilities subindustry, Concord Medical Services Holdings's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Concord Medical Services Holdings PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Concord Medical Services Holdings's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Concord Medical Services Holdings's PE Ratio without NRI falls into.


FRA:C2C
56GF Score
Concord Medical Services Holdings Ltd FRA:C2C
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Concord Medical Services Holdings EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-2.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of €-2.49 mean?
Concord Medical Services Holdings (FRA:C2C) has a EPS without NRI of €-2.49 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Concord Medical Services Holdings and its competitors. According to the industry distribution chart, Concord Medical Services Holdings ranks #82 out of 512 companies in the Healthcare Providers & Services industry, placing it in the top 16%.
Is Concord Medical Services Holdings' EPS without NRI too high?
Concord Medical Services Holdings' current EPS without NRI is €-2.49. Based on the distribution chart, Concord Medical Services Holdings ranks #82 out of 512 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Concord Medical Services Holdings has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Concord Medical Services Holdings' EPS without NRI compare to CCEL and GBCS?
According to the Healthcare Providers & Services industry distribution chart, Concord Medical Services Holdings ranks #82 out of 512 companies for EPS without NRI. This places Concord Medical Services Holdings in the top 16% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 11.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.55, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Concord Medical Services Holdings and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Concord Medical Services Holdings's current EPS without NRI is €-2.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Concord Medical Services Holdings stock overvalued right now?
Concord Medical Services Holdings (FRA:C2C) has a current EPS without NRI of €-2.49. The stock's GF Value™ is €8.97, compared to a current price of €6.25 — trading 30.3% below its estimated fair value. The current EPS without NRI is €-2.49. Concord Medical Services Holdings' overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Concord Medical Services Holdings (FRA:C2C), the current EPS without NRI is €-2.49 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Concord Medical Services Holdings (FRA:C2C) Overvalued in 2026?

Based on GuruFocus' analysis, Concord Medical Services Holdings stock appears to be undervalued. The current stock price of €6.25 is trading 30.3% below its estimated GF Value™ of €8.97.

Key valuation signals for FRA:C2C:

  • EPS without NRI: €-2.49
  • GF Value™: €8.97 vs. price of €6.25 (30.3% below fair value)
  • GF Score™: 56/100 with 6 warning signs

No single metric tells the full story. See the FRA:C2C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Concord Medical Services Holdings Business Description

Other Exchanges CCM:USA
Address Hanwei Plaza Building, No. 7 Guanghua Road, Room A1-A5, 26th Floor, East Area, Chaoyang District, Beijing, CHN, 100020
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Geographically, the company derives revenue from PRC.
56GF Score

Get the complete analysis for FRA:C2C

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.25
Price
€8.97
GF Value